ImmunoScape

ImmunoScape

Biotechnology Research Singapore, Central Singapore, Sg 30 employees
Employees
30
Contacts
4
Emails
4
Phones
1

ImmunoScape Overview

Headquarters
Singapore, Central Singapore, Sg
Website
immunoscape.com
Industry
Biotechnology Research
Employees
30
Founded
2016
Funding
250.0K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ImmunoScape

ImmunoScape is a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR cell therapies in the field of oncology. The company's proprietary Deep Immunomics technology platform enables highly sensitive, large-scale mining and immune profiling of T cells in cancer patient samples to identify novel, therapeutically relevant TCRs across multiple types of solid tumors. ImmunoScape has multiple discovery programs ongoing and will be progressing towards IND-enabling studies and entry into the clinic. To learn more, visit us at immunoscape.com and follow us on Twitter @immunoscape.

ImmunoScape Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

ImmunoScape Org Chart

Sample employees and titles
Name Title Contact
Adrian Woolfson Founder of Genyro. Board Director
Email
Romi Chandiramani Group Chief Financial Officer
Email
Neeraja Kulkarni Singapore Permanent Resident - Research
Email
Antonella Vitiello
Email Phone

Employees by Management Level

Individual contributor 6 profiles
Executive 3 profiles
Director 3 profiles
Manager 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 1
Executive 1 1 0

ImmunoScape Tech Stack

Data / AI 3 profiles

Compare Similar Companies to ImmunoScape